158 related articles for article (PubMed ID: 28521904)
1. Make immunological peace not war: Potential applications of tolerogenic dendritic cells.
Walton EL
Biomed J; 2017 Apr; 40(2):77-79. PubMed ID: 28521904
[TBL] [Abstract][Full Text] [Related]
2. Harnessing the properties of dendritic cells in the pursuit of immunological tolerance.
Horton C; Shanmugarajah K; Fairchild PJ
Biomed J; 2017 Apr; 40(2):80-93. PubMed ID: 28521905
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications.
Rutella S; Lemoli RM
Immunol Lett; 2004 Jun; 94(1-2):11-26. PubMed ID: 15234530
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological induction of tolerogenic dendritic cells and regulatory T cells.
Adorini L; Giarratana N; Penna G
Semin Immunol; 2004 Apr; 16(2):127-34. PubMed ID: 15036236
[TBL] [Abstract][Full Text] [Related]
5. What does the future hold for cell-based tolerogenic therapy?
Bluestone JA; Thomson AW; Shevach EM; Weiner HL
Nat Rev Immunol; 2007 Aug; 7(8):650-4. PubMed ID: 17653127
[TBL] [Abstract][Full Text] [Related]
6. Cell-based Tolerogenic Therapy, Experience from Animal Models of Multiple Sclerosis, Type 1 Diabetes and Rheumatoid Arthritis.
Stojanovic I; Dimitrijevic M; Vives-Pi M; Mansilla MJ; Pujol-Autonell I; Rodríguez-Fernandez S; Palova-Jelínkova L; Funda DP; Gruden-Movsesijan A; Sofronic-Milosavljevic L; Hilkens CMU; Martinez-Caceres E; Miljkovic D
Curr Pharm Des; 2017; 23(18):2623-2643. PubMed ID: 28201972
[TBL] [Abstract][Full Text] [Related]
7. Induction of tolerogenic dendritic cells by vitamin D receptor agonists.
Adorini L; Penna G
Handb Exp Pharmacol; 2009; (188):251-73. PubMed ID: 19031030
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles for the Induction of Antigen-Specific Immunological Tolerance.
Kishimoto TK; Maldonado RA
Front Immunol; 2018; 9():230. PubMed ID: 29515571
[TBL] [Abstract][Full Text] [Related]
9. Tolerogenic dendritic cells for autoimmune disease and transplantation.
Thomson AW; Robbins PD
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii90-6. PubMed ID: 19022823
[TBL] [Abstract][Full Text] [Related]
10. Novel delivery mechanisms for antigen-specific immunotherapy.
Neef T; Miller SD
Curr Opin Endocrinol Diabetes Obes; 2021 Aug; 28(4):404-410. PubMed ID: 34101653
[TBL] [Abstract][Full Text] [Related]
11. An optimized CFSE-based T-cell suppression assay to evaluate the suppressive capacity of regulatory T-cells induced by human tolerogenic dendritic cells.
Boks MA; Zwaginga JJ; van Ham SM; ten Brinke A
Scand J Immunol; 2010 Aug; 72(2):158-68. PubMed ID: 20618775
[TBL] [Abstract][Full Text] [Related]
12. Regulatory dendritic cells in autoimmunity: A comprehensive review.
Liu J; Cao X
J Autoimmun; 2015 Sep; 63():1-12. PubMed ID: 26255250
[TBL] [Abstract][Full Text] [Related]
13. Tolerogenic Dendritic Cells and T-Regulatory Cells at the Clinical Trials Crossroad for the Treatment of Autoimmune Disease; Emphasis on Type 1 Diabetes Therapy.
Phillips BE; Garciafigueroa Y; Engman C; Trucco M; Giannoukakis N
Front Immunol; 2019; 10():148. PubMed ID: 30787930
[TBL] [Abstract][Full Text] [Related]
14. New trends in immunosuppression and immunotherapy.
Jiang S; Lombardi G
Int Immunopharmacol; 2006 Dec; 6(13-14):1874-8. PubMed ID: 17161339
[TBL] [Abstract][Full Text] [Related]
15. Future therapeutics for the induction of peripheral immune tolerance in autoimmune disease and organ transplantation.
Cobbold SP
Immunotherapy; 2009 May; 1(3):447-60. PubMed ID: 20635961
[TBL] [Abstract][Full Text] [Related]
16. Treating autoimmune diseases through restoration of antigen-specific immune tolerance.
Wolfraim LA
Arch Immunol Ther Exp (Warsz); 2006; 54(1):1-13. PubMed ID: 16642252
[TBL] [Abstract][Full Text] [Related]
17. Myosin-primed tolerogenic dendritic cells ameliorate experimental autoimmune myocarditis.
Lee JH; Kim TH; Park HE; Lee EG; Jung NC; Song JY; Seo HG; Seung KB; Chang K; Lim DS
Cardiovasc Res; 2014 Feb; 101(2):203-10. PubMed ID: 24189626
[TBL] [Abstract][Full Text] [Related]
18. Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy.
Gonzalez-Rey E; Anderson P; Delgado M
Ann Rheum Dis; 2007 Nov; 66 Suppl 3(Suppl 3):iii70-6. PubMed ID: 17934101
[TBL] [Abstract][Full Text] [Related]
19. Tolerogenic dendritic cells and induction of T suppressor cells in transplant recipients.
Vlad G; Suciu-Foca N
Methods Mol Biol; 2013; 1034():359-71. PubMed ID: 23775751
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin-like transcript 3: A crucial regulator of dendritic cell function.
Vlad G; Chang CC; Colovai AI; Berloco P; Cortesini R; Suciu-Foca N
Hum Immunol; 2009 May; 70(5):340-4. PubMed ID: 19275918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
